Cenduit LLC Moves to New U.S. Headquarters in Research Triangle Park as it Continues Delivering on Promise to Change the Economics of Clinical Trials


Collaborative workspace that supports agile technology development is a key component of strategic technology and operational investments to meet life sciences industry’s growing need for innovative eClinical technologies 

October 21, 2019– Durham, NC  Cenduit LLC people, processes and technologies are improving the economics and safety of clinical studies through quality, innovation, and expertise. 

As it operates at the nexus of technology and healthcare, Cenduit continues to make long-term investments to support its commitment to steadfast, high-service client delivery across its locations in the U.S., Europe and Asia-Pacific. In September, Cenduit moved its U.S. headquarters to Frontier RTP – a contemporary community of growing businesses that provides a collaborative environment for RTP’s most talented professionals and developers within biopharma, healthcare and technology. 

“Over the past few years, our team has undergone an incredible transformation, building the next chapter at Cenduit,” said Cenduit CEO Sam Osman. “We’re pleased to have our new corporate headquarters in the heart of RTP’s biopharma and technology community. As we help our clients navigate the second half of 2019 and beyond, our expert team continues to live and breathe its unyielding commitment to consistently innovating eClinical technology solutions.”

Chris Dailey, Cenduit Vice President of Global Technology, added, “Incredibly talented people strive to be part of the Cenduit Digital Pack development team. Our collaborative environment, convenient location and culture of continuous innovation makes it easy for them to be part of our collective goal - to improve the way our industry designs, builds and manages clinical trials.”

This year, Cenduit has also significantly expanded Asia-Pacific operations (read the news release about Cenduit’s new Bangalore office here), and increased global headcount in project management, development, and service delivery across three regions. 

“Cenduit exemplifies the spirit of innovation and partnership that defines Frontier RTP,” says Scott Levitan, president and CEO of Research Triangle Park. “We welcome the company, and look forward to Cenduit becoming an important part of the fabric of our growing technology community.”

2019 highlights to-date on the company also include…

Corporate Growth – Biopharma industry veteran Howard Brand joined Cenduit as CFO to direct financial operations and support the company’s overall growth strategy. Brand held previous executive roles at organizations including PRA Health Sciences and PPD. Glen Wright Colopy, D.Phil. Engineering Science the University of Oxford, joined Cenduit as a Scientific Officer. Colopy is a frequent presenter with the University of Oxford’s academic consortiums and symposiums surrounding clinical informatics. 

Industry Recognition - The respected industry magazine PharmaVOICE continues to recognize Cenduit C-Suite executive leaders for their contributions toward improving clinical trials. This year, CEO Sam Osman was named to the prestigious 2019 PharmaVOICE 100 list of the world’s most influential life sciences professionals. Osman was recognized for his dedication to modernize eClinical technology, industrialize the operations of eClinical providers and sponsors, and reinforce a philosophy to “do the right thing, always.” (In 2018, Cenduit COO Jennifer Aquino was also named to the PharmaVOICE 100.) Sam Osman also was honored as one of the Triangle Business Journal’s 40 Under 40 most inspiring business people in the Research Triangle area, recognizing his pivotal leadership role in the Cenduit transformation over the past several years since taking the helm as Cenduit’s CEO, and commitment to giving back to the broader community.

About Cenduit LLC

Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise and client-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps clients manage clinical studies in over 100 countries, interacting with over 1,000,000 patients at nearly 33,000 sites. Visit www.cenduit.com for more information.


Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393

Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253


IRT, Quantum InteractiveCenduit